Joint statement: management of the third stage of labour to prevent post-partum haemorrhage.
D005260:Female; D006801:Humans; D007749:Labor Stage, Third / Q000187:drug effects*; D007743:Labor, Obstetric / Q000187:drug effects; D008880:Midwifery / Q000592:standards*; D009774:Obstetrics / Q000592:standards*; D010120:Oxytocics / Q000627:therapeutic use*; D006473:Postpartum Hemorrhage / Q000517:prevention & control*; D011247:Pregnancy; D012955:Societies, Medical; D012956:Societies, Nursing
D010120:Oxytocics